COVID-19: Information on ASPIRA LABS Operations

Click to Learn More
  • Home
  • Recent News and Upcoming Events

Recent News and Upcoming Events

Recent News


  • Aspira Women’s Health, Inc. to Participate in Virtual Investor Events

    Aspira to participate in the 10th Annual LifeSci Advisors Corporate Access Event and  Biotech Showcase™ from January 6 – 15th, 2021 For a pdf of this press release please click here AUSTIN, Texas — January 4, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in…

  • Aspira Women’s Health, Inc. Announces a Collaborative Agreement with Baylor Genetics for the Co-Development of an Ovarian Cancer Early-Detection test

    For a pdf of this press release please click here AUSTIN, Texas — November 19, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into a collaborative research agreement with Baylor Genetics (Houston, TX) to co-develop a novel Ovarian Cancer early-detection test. Ovarian cancer accounts for…

  • Aspira Women’s Health Reports Third Quarter 2020 Financial Results

    Conference Call scheduled for today, November 12th at 4:30 p.m. ET For a pdf of this press release please click here AUSTIN, Texas — November 12, 2020 — Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the third quarter ended September 30,…

  • Aspira Women’s Health, Inc. Strengthens Executive Leadership with New Appointments

    Team comprised of distinguished healthcare industry leaders in clinical development, translational medicine, strategy, and operational excellence, joins forces to accelerate innovation and market leadership position For a pdf of this press release please click here AUSTIN, Texas — November 10, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company today announces…

  • Aspira Women’s Health Strengthens Board of Directors with the Addition of Dr. Sandra E. Brooks

    AUSTIN, Texas — November 9, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Sandra E. Brooks, MD, MBA to its Board of Directors.  The addition of Dr. Brooks brings the Board composition to seven members with the majority now female. “It’s a tremendous honor to welcome Dr. Brooks…

Investor Relations